Search Results
34 items found for "Michael Decker"
- Ep 146 with Dr Michael Feigin
Michael Feigin About Dr. Michael Feigin "Dr. Michael Feigin is an Associate Professor in the Department of Pharmacology and Therapeutics, and Director Michael Feigin on the web Roswell Park Feigin Lab Google Scholar LinkedIn Twitter Dr.
- Ep 48 with Dr Nyla Naim Dr Michael Lemieux Dr Jason Nasse from Addgene
Michael Lemieux & Dr. Jason Nasse About Dr. Michael Lemieux ''My name is Michael (Mike) Lemieux and I am a Connecticut native. Michael Lemieux on the web Addgene Blog Dr. GPCR Ecosystem About Dr. Jason Nasse Dr.
- Ep 20 with Dr. Jennifer Pluznick
She then spent five years training as a postdoctoral fellow in the laboratory of Michael Caplan at Yale
- Ep 14 with Dr. Bryan Roth
Bryan Roth is the Michael Hooker Distinguished Professor of Pharmacology at the University of North Carolina
- G protein coupled receptor transcripts in human immune cells and platelets
Hansen, Daniel Martin, Florian Langer, Kathleen Harrison, John Kehrl, Claudia Cicala, Elena Martinelli, Michael
- Chemokine Physiology in Cancer
Authors Donovan Drouillard, Brian T Craig, Michael B Dwinell Tags Chemokine receptor; cell migration;
- CCR7 acts as both a sensor and a sink for CCL19 to coordinate collective leukocyte migration
, Mehmet Can Uçar , Nikola Canigova , Julian Stopp , Jan Schwarz , Jack Merrin , Edouard Hannezo , Michael
- Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer
Michael's Hospital, University of Toronto.
- Systems modeling of oncogenic G-protein and GPCR signaling reveals unexpected differences in downstream pathway activation
Authors Michael Trogdon, Kodye Abbott, Nadia Arang, Kathryn Lande, Navneet Kaur, Melinda Tong, Mathieu
- Delivery of US28 by incoming HCMV particles rapidly attenuates Akt activity to suppress HCMV lytic replication in monocytes
Authors Jamil Mahmud, Brittany W Geiler, Juthi Biswas, Michael J Miller, Julia E Myers, Stephen M Matthews
- Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Costa, Noriko Nishimura, Tasmin Farzana, Colin Rueda, David J Chung, Heather J Landau, Oscar B Lahoud, Michael
- Ep 36 with Dr. Michel Bouvier
Michel Bouvier About Dr. Michel Bouvier Michel Bouvier is a professor of Biochemistry and Molecular Medicine and the CEO of the Michel’s scientific contributions were recognized by the attribution of many awards and distinctions As some of you may know, Michel was one of my professors at the Universite de Montreal. I spent some time working in Michel’s lab with some of his postdocs and although I was never officially
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Michael Schaefer’s group at Leipzig University, Germany, focusing on drug screening and utilizing electrophysiological Mancini (2), Samya Aouad (2,3), Herthana Kandasamy (2), Sandra Morrissette (2), Arhamatoulaye Maiga (4), Michel
- Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non-ischaemic heart failure
Daniel Scheiber , Harald Heidecke , Ralf Dechend , Carmen Barthuber , Sina Kaufmann , Malte Kelm , Michael
- Distinct sub-cellular signal propagation as a component of functional selectivity
component of functional selectivity Date & Time Saturday, November 4th / 8:15 AM Abstract Coming Soon About Michel Bouvier "Michel Bouvier is a professor of Biochemistry and Molecular Medicine and the CEO of the Institute Michel’s scientific contributions were recognized by the attribution of many awards and distinctions Michel Bouvier on the web Wikipedia IRIC Bouvier Lab Google Scholar Pubmed ResearchGate Twitter LinkedIn
- GPCR Retreat Committee 2023 | Dr. GPCR Ecosystem
Michel Bouvier Dr. Stéphane Laporte Dr. Martin Audet Dr. Stephen Ferguson Dr. Richard Leduc Dr.
- Ep 77 with Martin Audet
Strong education with a Doctor of Philosophy (Ph.D.) in biochemistry under the supervision of Michel
- Cannabinoid compounds to augment L-DOPA treatment in Parkinson's Disease
Michel Bouvier working on the topic of GPCR dimerization/oligomerization.
- Ep 17 with Dr. Yamina Berchiche
Michel Bouvier’s class as an undergraduate student at the University of Montreal in early 2000.
- Ep 15 with Dr. Arun Shukla
Hartmut Michel . Fascinated by GPCRs he wrote to Dr.
- Session I | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Pan, Michael Holinstat and Gregory G.
- Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML
, Kelsey-Leigh A Garcia , Mary-Elizabeth M Percival , Ryan D Cassaday , Vivian G Oehler , Pamela S Becker
- Ep 92 with Dr. Stephane Angers
Michel Bouvier .
- Ep 100 with Dr Caron Tribute Part 1
Michel Bouvier (1985) Dr. Kathleen Caron - Co-host- (1970) Dr. Richard Cerione (1985) Dr.
- Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia
Aguilar, Lauren Hagen, Jeannine McCune, Richard Gelinas, Raymond J Monnat Jr, Ilya Shmulevich, Pamela S Becker
- Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
Authors Peter J P Croucher , Maya Ridinger , Pamela S Becker , Tara L Lin , Sandra L Silberman , Eunice
- Identification of Small-Molecule Antagonists Targeting the Growth Hormone Releasing Hormone Receptor (GHRHR)
Authors Minos-Timotheos Matsoukas, Tarryn Radomsky, Vasilis Panagiotopoulos, Robin du Preez, Michail
- Expression prevalence and dynamics of GPCR somatostatin receptors 2 and 3 as cancer biomarkers beyond NET: a paired immunohistochemistry approach
Authors Mor Oron-Herman , David Kirmayer , Amelie Lupp , Stefan Schulz , Genady Kostenich , Michel Afargan